Franklin Resources
RYTM icon

Franklin Resources’s Rhythm Pharmaceuticals RYTM Stock Holding History

Franklin Resources’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.1M Sell
577,033
-49,812
-8% -$4.5M 0.01% 596
2026
Q1 		$54.5M Sell
626,845
-68,890
-10% -$6.7M 0.01% 622
2025
Q4 		$74.5M Buy
695,735
+127,953
+23% +$13.6M 0.02% 513
2025
Q3 		$57.3M Buy
567,782
+23,980
+4% +$2.23M 0.01% 595
2025
Q2 		$34.4M Buy
543,802
+217,642
+67% +$13.3M 0.01% 750
2025
Q1 		$17.3M Buy
326,160
+57,955
+22% +$3.22M 0.01% 944
2024
Q4 		$15M Buy
268,205
+8,789
+3% +$485K ﹤0.01% 992
2024
Q3 		$13M Buy
259,416
+26,739
+11% +$1.28M ﹤0.01% 1035
2024
Q2 		$9.55M Buy
232,677
+11,772
+5% +$470K ﹤0.01% 1094
2024
Q1 		$9.57M Buy
220,905
+215,029
+3,659% +$9.41M ﹤0.01% 1094
2023
Q4 		$270K Buy
+5,876
New +$185K ﹤0.01% 2231
2022
Q3 		– Sell
-1,779,465
Closed -$7.38M – 2390
2022
Q2 		$7.38M Buy
1,779,465
+11
+0% +$60 ﹤0.01% 1023
2022
Q1 		$20.5M Buy
1,779,454
+242,582
+16% +$2.13M 0.01% 851
2021
Q4 		$15.3M Buy
1,536,872
+1,368,789
+814% +$15.4M 0.01% 957
2021
Q3 		$2.19M Buy
+168,083
New +$2.57M ﹤0.01% 1427
2018
Q2 		– Sell
-107,900
Closed -$2.15M – 1525
2018
Q1 		$2.15M Sell
107,900
-139,000
-56% -$3.69M ﹤0.01% 1196
2017
Q4 		$7.17M Buy
+246,900
New +$6.53M ﹤0.01% 1013

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources's RYTM Position: Q2 2026 in Review

Franklin Resources reduced its Rhythm Pharmaceuticals (RYTM) stake by 7.9% in Q2 2026, selling an estimated $4.5M and leaving 577,033 shares worth $64.1M. The position accounts for 0.01% of the portfolio, ranked #596.

Franklin Resources first reported a position in RYTM in Q4 2017 and has held it in 17 quarters since. The position peaked at $74.5M in Q4 2025. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Franklin Resources held 577,033 shares of Rhythm Pharmaceuticals worth $64.1M as of Q2 2026.
  • Franklin Resources sold 49,812 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $4.5M.
  • Rhythm Pharmaceuticals made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #596 holding.
  • Franklin Resources first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 17 quarters since.
  • Franklin Resources's Rhythm Pharmaceuticals position peaked at $74.5M in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.